IGF2 and glioblastoma: According to previous studies, miR-491-5p inhibits the autophagy signaling pathway by targeting insulin-like growth factor 2 (IGF2) [87] and participates in autophagy in GBM by regulating the MAPK, PI3K/Akt, and mTOR pathways [88, 89].